Literature DB >> 18417721

Downregulation of hepatic acetylation of drugs in chronic renal failure.

Emilie Simard1, Judith Naud, Josée Michaud, Francois A Leblond, Alain Bonnardeaux, Chantal Guillemette, Edith Sim, Vincent Pichette.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18417721      PMCID： PMC2440299          DOI： 10.1681/ASN.2007090974

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  48 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  The pharmacokinetics of single doses of metoclopramide in renal failure.

Authors:  D N Bateman; R Gokal; T R Dodd; P G Blain
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

3.  Hepatic drug metabolism in rats with experimental chronic renal failure.

Authors:  S E Patterson; V H Cohn
Journal:  Biochem Pharmacol       Date:  1984-03-01       Impact factor: 5.858

4.  Metabolism of procainamide in patients with chronic heart failure, chronic respiratory failure and chronic renal failure.

Authors:  P du Souich; S Erill
Journal:  Eur J Clin Pharmacol       Date:  1978-11-09       Impact factor: 2.953

5.  New spectrophotometric and radiochemical assays for acetyl-CoA: arylamine N-acetyltransferase applicable to a variety of arylamines.

Authors:  H H Andres; A J Klem; S M Szabo; W W Weber
Journal:  Anal Biochem       Date:  1985-03       Impact factor: 3.365

6.  Metoclopramide kinetics in patients with impaired renal function and clearance by hemodialysis.

Authors:  C R Lehmann; J D Heironimus; C B Collins; T J O'Neil; W P Pierson; J T Crowe; A P Melikian; G J Wright
Journal:  Clin Pharmacol Ther       Date:  1985-03       Impact factor: 6.875

Review 7.  Renal disease and drug metabolism: an overview.

Authors:  T P Gibson
Journal:  Am J Kidney Dis       Date:  1986-07       Impact factor: 8.860

Review 8.  Clinical pharmacokinetics of procainamide.

Authors:  E Karlsson
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

9.  Effects of uremic toxins on hepatic uptake and metabolism of erythromycin.

Authors:  Hong Sun; Yong Huang; Lynda Frassetto; Leslie Z Benet
Journal:  Drug Metab Dispos       Date:  2004-07-30       Impact factor: 3.922

10.  Kinetics of arylamine N-acetyltransferase in tissues from rapid and slow acetylator mice.

Authors:  S S Mattano; W W Weber
Journal:  Carcinogenesis       Date:  1987-01       Impact factor: 4.944
View more
  9 in total

1.  Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers.

Authors:  Daniel V Neves; Vera L Lanchote; Miguel Moysés Neto; José A Cardeal da Costa; Carolina P Vieira; Eduardo B Coelho
Journal:  Br J Clin Pharmacol       Date:  2016-04-07       Impact factor: 4.335

2.  Reduced hepatic synthesis of calcidiol in uremia.

Authors:  Josée Michaud; Judith Naud; Denis Ouimet; Christian Demers; Jean-Luc Petit; Francois A Leblond; Alain Bonnardeaux; Marielle Gascon-Barré; Vincent Pichette
Journal:  J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 10.121

Review 3.  Consequences of renal failure on non-renal clearance of drugs.

Authors:  Laure Lalande; Bruno Charpiat; Gilles Leboucher; Michel Tod
Journal:  Clin Pharmacokinet       Date:  2014-06       Impact factor: 6.447

Review 4.  The effect of chronic renal failure on drug metabolism and transport.

Authors:  Albert W Dreisbach; Juan J L Lertora
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-08       Impact factor: 4.481

5.  In vivo alterations in drug metabolism and transport pathways in patients with chronic kidney diseases.

Authors:  Melanie S Joy; Reginald F Frye; Thomas D Nolin; Brittney V Roberts; Mary K La; Jinzhao Wang; Kim L R Brouwer; Mary Anne Dooley; Ronald J Falk
Journal:  Pharmacotherapy       Date:  2013-09-06       Impact factor: 4.705

Review 6.  Pharmacokinetics and dosage adjustment in patients with renal dysfunction.

Authors:  Roger K Verbeeck; Flora T Musuamba
Journal:  Eur J Clin Pharmacol       Date:  2009-06-20       Impact factor: 2.953

7.  Use of enantiomeric bupropion and hydroxybupropion to assess CYP2B6 activity in glomerular kidney diseases.

Authors:  Melanie S Joy; Reginald F Frye; Kristi Stubbert; Kim R Brouwer; Ronald J Falk; Evan D Kharasch
Journal:  J Clin Pharmacol       Date:  2010-01-26       Impact factor: 3.126

Review 8.  Emerging Roles of Aryl Hydrocarbon Receptors in the Altered Clearance of Drugs during Chronic Kidney Disease.

Authors:  Tacy Santana Machado; Claire Cerini; Stéphane Burtey
Journal:  Toxins (Basel)       Date:  2019-04-07       Impact factor: 4.546

Review 9.  Pharmacokinetics in children with chronic kidney disease.

Authors:  Anne M Schijvens; Saskia N de Wildt; Michiel F Schreuder
Journal:  Pediatr Nephrol       Date:  2019-08-02       Impact factor: 3.714
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.